Erstellt von klostergang

Eagle Pharmaceuticals Inc diskutieren

Eagle Pharmaceuticals Inc

WKN: A1XEDS / Symbol: EGRX / Name: Eagle Pharms / Aktie / Pharmazeutika / Small Cap /

Einschätzung Buy

Rendite (%)

Kursziel 95,00

Veränderung

Endet am

Fly like :

Eagle Pharmaceuticals (NASDAQ:EGRX) submits a New Drug Application (NDA) to the FDA for a stable liquid intravenous formulation (ready-to-use or RTU) of bivalirudin for the treatment of patients undergoing percutaneous coronary intervention (PCI) in the following scenarios: with the use of a glycoprotein IIb/IIIa inhibitor or at risk of heparin-induced thrombocytopenia and thrombosis syndrome and patients with unstable angina undergoing percutaneous transluminal coronary angioplasty.
RTU bivalirudin, intended for use with aspirin, contains the same active ingredient as The Medicines Company's (NASDAQ:MDCO) Angiomax (bivalirudin), but eliminates the need for reconstitution/dilution.
Angiomax generated ~$600M in sales in 2014.
Bivalirudin is an anticoagulant that inhibits thrombin.

klostergang

Einschätzung Buy

Rendite (%)

Kursziel 95,00

Veränderung

Endet am

(Laufzeit überschritten)

klostergang

Einschätzung Buy

Rendite (%)

Kursziel 65,00

Veränderung

Endet am

😤

melinda

Einschätzung Buy

Rendite (%)

Kursziel 58,63

Veränderung

Endet am

Wird fortgesetzt

😤

melinda

Einschätzung Buy

Rendite (%)

Kursziel 58,63

Veränderung

Endet am

(Vom Mitglied beendet)

melinda

Einschätzung Buy

Rendite (%)

Kursziel 71,71

Veränderung

Endet am

SecteurProduits pharmaceutiques Agenda 13/09 | 22:05 Présentation

Métier

Develops and manufactures pharmaceutical preparations

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products.

Its products include argatroban; ryanodex; docetaxel injection, non-alcohol formulation; and bendeka.

The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.

Nombre d'employés : 108 personnes.

melinda